Lantern Pharma investor relations material

Lantern Pharma is a clinical stage biotechnology company whose clinical programs target patients that have limited or poor options. Lantern's revolutionary AI platform, RADR®, uses leading edge machine learning techniques to help optimize drug development and clinical trial design, identify potential new indications for approved drugs, and improve the success of oncology clinical trials.